{"id":21549,"date":"2016-09-01T05:00:48","date_gmt":"2016-08-31T23:30:48","guid":{"rendered":"https:\/\/cardiophile.org\/?p=21549"},"modified":"2022-06-15T20:08:41","modified_gmt":"2022-06-15T14:38:41","slug":"drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/","title":{"rendered":"Drugs approved for treatment of normotensive patients with pulmonary embolism"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/Q49QSgNIv8g\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Drugs approved for treatment of normotensive patients with pulmonary embolism:<\/span><\/h2>\n<ol>\n<li>Heparin<\/li>\n<li>Fondaparinux<\/li>\n<li>Rivaroxaban<\/li>\n<li>Apixaban<\/li>\n<li>Dabigatran<\/li>\n<li>Edoxaban<\/li>\n<\/ol>\n<p>Thrombolytic therapy is reserved for rescue in case of decompensation due to right ventricular failure or recurrence of pulmonary embolism in these stable patients.<\/p>\n<p>Dabigatran is a direct thrombin inhibitor while rivaroxaban, apixaban and edoxaban are oral factor Xa inhibitors. Fondaparinux is a parenteral factor Xa inhibitor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin Fondaparinux Rivaroxaban Apixaban Dabigatran Edoxaban Thrombolytic therapy is reserved for rescue in case of decompensation due to right ventricular failure or recurrence of pulmonary embolism in these stable patients. Dabigatran is a direct thrombin inhibitor while rivaroxaban, apixaban and edoxaban are oral factor Xa [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":40116,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-21549","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cardiology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drugs for treatment of normotensive patients with pulmonary embolism<\/title>\n<meta name=\"description\" content=\"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drugs for treatment of normotensive patients with pulmonary embolism\" \/>\n<meta property=\"og:description\" content=\"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-31T23:30:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-15T14:38:41+00:00\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Drugs approved for treatment of normotensive patients with pulmonary embolism\",\"datePublished\":\"2016-08-31T23:30:48+00:00\",\"dateModified\":\"2022-06-15T14:38:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/\"},\"wordCount\":73,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"articleSection\":[\"Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/\",\"name\":\"Drugs for treatment of normotensive patients with pulmonary embolism\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-08-31T23:30:48+00:00\",\"dateModified\":\"2022-06-15T14:38:41+00:00\",\"description\":\"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Drugs approved for treatment of normotensive patients with pulmonary embolism\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drugs for treatment of normotensive patients with pulmonary embolism","description":"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/","og_locale":"en_US","og_type":"article","og_title":"Drugs for treatment of normotensive patients with pulmonary embolism","og_description":"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.","og_url":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2016-08-31T23:30:48+00:00","article_modified_time":"2022-06-15T14:38:41+00:00","author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Drugs approved for treatment of normotensive patients with pulmonary embolism","datePublished":"2016-08-31T23:30:48+00:00","dateModified":"2022-06-15T14:38:41+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/"},"wordCount":73,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#primaryimage"},"thumbnailUrl":"","articleSection":["Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/","url":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/","name":"Drugs for treatment of normotensive patients with pulmonary embolism","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-08-31T23:30:48+00:00","dateModified":"2022-06-15T14:38:41+00:00","description":"Drugs approved for treatment of normotensive patients with pulmonary embolism: Heparin, Fondaparinux, Rivaroxaban, Apixaban, Dabigatran and Edoxaban.","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/drugs-approved-for-treatment-of-normotensive-patients-with-pulmonary-embolism\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Drugs approved for treatment of normotensive patients with pulmonary embolism"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=21549"}],"version-history":[{"count":2,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21549\/revisions"}],"predecessor-version":[{"id":53949,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/21549\/revisions\/53949"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=21549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=21549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=21549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}